Antithrombotic Therapies in COVID-19 Disease: a Systematic Review

Conclusion(s): New evidence on thromboembolism in COVID-19 does not warrant a change in current guidance on thromboprophylaxis among hospitalized patients. Prospective trials of antithrombotic treatment strategies among patients with COVID-19 are urgently needed.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news